Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period

Affected assets and topics

Article tone

Expected market reaction

Evidence trail

Prediction lifecycle

• Free Analysis Rule Based Analysis not AI NASDAQ Bullish 60% 6h
  Generated → 6h → Excluded

  Expired: not evaluated within 7 days of its 6h timeframe elapsing

Logged at publication, scored automatically once the window closes — never edited.

Original source

HONG KONG, July 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over the counter (“OTC”) pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced that it received a notification letter (the “Notification Letter”) on July 14, 2026 from Nasdaq's Listing Qualifications Department indicating that the Company has been granted an additional 180 calendar day period, or until January 11, 2027, to regain c

Read the full article on Yahoo Finance

Original article published by Yahoo Finance on July 16, 2026. Analysis and insights provided by AnalystMarkets AI.

More of the NASDAQ narrative

• 13:34 The Nasdaq Slips as Mounting Macro Worries Weigh on Stocks Yahoo Finance
• 11:38 Wall Street headed into the red, bond markets are twitchy, while oil keeps pushing higher Yahoo Finance
• 11:30 Tactical Resources to Ring the Nasdaq Closing Bell Yahoo Finance
• 08:41 Nasdaq Futures Slip As Rising Iran Tensions, Oil, Treasury Yields Keep Wall Street On Edge: NVDA, DELL, CRDO, NIO, RKLB, MSTR In Focus Yahoo Finance